
Results
2
2 companies
Hyloris Pharmaceuticals
Market Cap: €162.4m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.80
7D
-11.3%
1Y
-9.4%
argenx
Market Cap: €36.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€599.80
7D
-5.2%
1Y
6.3%